S0003642

Zidovudine 300mg tabs/PAC-60


Zidovudine 300mg film coated tablets, bottle or blister pack of 60
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description
Zidovudine 300mg film coated tablets, pack of 60

Technical Specifications
Each film coated tablet contains 300mg Zidovudine.

Therapeutic class
Zidovudine (ZDV) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI).

Standard shelf life
36 months

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications
Management of HIV infection in adults and children in combination with at least two other antiretroviral drugs. By mouth (oral), PO
PMTCT: In combination with other drugs for prevention of mother-to child HIV transmission.

Packaging and storage
Store below 30ºC (86ºF).
Protect from light.
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack

Regulatory Status
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items


Related Products